ISOFOL — Isofol Medical AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK198.74m
- SEK88.00m
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million
Brief: Isofol Medical Announces Bfarm Approval Of Optimized Phase Ib/Ii Study Design
Brief: Isofol Gets Gross Proceeds Of SEK 18.9 Mln In Connection With Exercise Of Warrants And Guarantee Commitments
Brief: Isofol Secures License Rights For Arfolitixorin In Autism
Brief: Isofol Medical Proposes No Dividend For 2025
Sweden's Isofol Medical Q4 loss narrows
Brief: EPO To Grant New Patent For Isofol's Arfolitixorin
Brief: Isofol Medical: EPO Intention To Grant For Arfolitixorin Patent
Brief: Isofol Medical Q3 Net Income SEK -13.064 Million
Brief: Isofol Medical Q2 Net Income SEK -14.67 Million
Brief: Isofol Successfully Completes Pre-Ind Meeting With FDA For Arfolitixorin
Brief: Isofol's Rights Issue Fully Subscribed
Brief: Isofol Medical Sets Rights Issue Subscription Price At SEK 0.80 Per Share
Brief: Isofol Gets Pre-Ind Meeting With FDA For Arfolitixorin
Brief: Isofol Medical Q1 Net Income SEK -13.657 Million
Brief: Isofol Resolves On Rights Issue Of Units Of Around SEK 85 Mln
Brief: Isofol - Solasia Pharma To Invest SEK 140 Mln In Arfolitixorin Trials In Japan
Brief: Isofol Medical Q4 Net Income SEK 13.102 Million
Brief: Isofol Medical Q3 Loss For Period Widens To SEK 10.9 Mln